Well Characterized Biologicals, IBC
Meet up with Albumedix at the 2017 Well Characterized Biologicals, IBC
FORMULATE WITH CONFIDENCE
Recombumin® is an effective versatile stabilizer particularly suited for the formulation of biological drugs and vaccines that are not readily stabilized using traditional formulation strategies.
Maximizing the stability of a therapeutic protein, peptide or vaccine is not an easy task and therefore, a critical objective of any drug development program. Physical and chemical instability of biological drugs and vaccine formulations are a source of dosage form inefficacy and also undesirable immunogenic responses. Therefore, optimizing the stability of a therapeutic drug during final drug formulation, handling and storage is imperative to producing a safe final product with an appropriate shelf-life.
Albumedix's ground-breaking Recombumin®, recombinant human albumin products provide drug formulators with a unique alternative to traditional stabilizers when working with challenging molecules such as complex drug conjugates, high-concentration biotherapeutics, highly potent drugs or instable therapeutic peptides. By utilizing the versatile properties of Recombumin®, drug developers can overcome several critical formulation challenges:
Through working closely with partners and collaborators, and using our collective scientific, technology and regulatory expertise, Albumedix strives to bring valuable yet initially unstable drug candidates to market. By combining Recombumin® with our partners' innovative drug candidates, the technology has been established as a commercially validated, safe stabilization solution across a broad range of drug types and indications. Read more.